期刊文献+

Stages based molecular mechanisms for generating cholangiocytes from liver stem/progenitor cells 被引量:3

Stages based molecular mechanisms for generating cholangiocytes from liver stem/progenitor cells
下载PDF
导出
摘要 Except for the most organized mature hepatocytes,liver stem/progenitor cells(LSPCs)can differentiate into many other types of cells in the liver including cholangiocytes.In addition,LSPCs are demonstrated to be able to give birth to other kinds of extra-hepatic cell types such as insulin-producing cells.Even more,under some bad conditions,these LSPCs could generate liver cancer stem like cells(LCSCs)through malignant transformation.In this review,we mainly concentrate on the molecular mechanisms for controlling cell fates of LSPCs,especially differentiation of cholangiocytes,insulin-producing cells and LCSCs.First of all,to certificate the cell fates of LSPCs,the following three features need to be taken into account to perform accurate phenotyping:(1)morphological properties;(2)specific markers;and(3)functional assessment including in vivo transplantation.Secondly,to promote LSPCs differentiation,systematical attention should be paid to inductive materials(such as growth factors and chemical stimulators),progressive materials including intracellular and extracellular signaling pathways,and implementary materials(such as liver enriched transcriptive factors).Accordingly,some recommendations were proposed to standardize,optimize,and enrich the effective production of cholangiocyte-like cells out of LSPCs.At the end,the potential regulating mechanisms for generation of cholangiocytes by LSPCs were carefully analyzed.The differentiation of LSPCs is a gradually progressing process,which consists of three main steps:initiation,progression and accomplishment.It’s the unbalanced distribution of affecting materials in each step decides the cell fates of LSPCs. Except for the most organized mature hepatocytes, liver stem/progenitor cells (LSPCs) can differentiate into many other types of cells in the liver including cholangiocytes. In addition, LSPCs are demonstrated to be able to give birth to other kinds of extra-hepatic cell types such as insulin-producing cells. Even more, under some bad conditions, these LSPCs could generate liver cancer stem like cells (LCSCs) through malignant transformation. In this review, we mainly concentrate on the molecular mechanisms for controlling cell fates of LSPCs, especially differentiation of cholangiocytes, insulin-producing cells and LCSCs. First of all, to certificate the cell fates of LSPCs, the following three features need to be taken into account to perform accurate phenotyping: (1) morphological properties; (2) specific markers; and (3) functional assessment including in vivo transplantation. Secondly, to promote LSPCs differentiation, systematical attention should be paid to inductive materials (such as growth factors and chemical stimulators), progressive materials including intracellular and extracellular signaling pathways, and implementary materials (such as liver enriched transcriptive factors). Accordingly, some recommendations were proposed to standardize, optimize, and enrich the effective production of cholangiocyte-like cells out of LSPCs. At the end, the potential regulating mechanisms for generation of cholangiocytes by LSPCs were carefully analyzed. The differentiation of LSPCs is a gradually progressing process, which consists of three main steps: initiation, progression and accomplishment. It’s the unbalanced distribution of affecting materials in each step decides the cell fates of LSPCs.
出处 《World Journal of Gastroenterology》 SCIE CAS 2013年第41期7032-7041,共10页 世界胃肠病学杂志(英文版)
基金 Supported by The National Natural Science Foundation of China,No.81302168,No.81172061,No.81370016 and No.81170419
关键词 LIVER stem/progenitor cells CHOLANGIOCYTES BILIARY differentiation Unbalanced distribution of materials Cell therapy Liver stem/progenitor cells Cholangiocytes Biliary differentiation Unbalanced distribution of materials Cell therapy
  • 相关文献

参考文献89

  • 1RenQingFENG LiYingDU ZhenQuanGUO.In vitro cultivation and differentiation of fetal liver stem cells from mice[J].Cell Research,2005,15(5):401-405. 被引量:9
  • 2Sarah–Fee Katz,André Lechel,Anna C. Obenauf,Yvonne Begus–Nahrmann,Johann M. Kraus,Eva M. Hoffmann,Johanna Duda,Parisa Eshraghi,Daniel Hartmann,Birgit Liss,Peter Schirmacher,Hans A. Kestler,Michael R. Speicher,K. Lenhard Rudolph.Disruption of Trp53 in Livers of Mice Induces Formation of Carcinomas With Bilineal Differentiation[J]. Gastroenterology . 2012 (5) 被引量:1
  • 3WeitaoZhang,WeihongLi,BaoqingLiu,PingWang,WenLi,HaiyanZhang.Efficient generation of functional hepatocyte‐like cells from human fetal hepatic progenitor cells in vitro[J]. J. Cell. Physiol. . 2012 (5) 被引量:1
  • 4Nan You,Weihui Liu,Xiao Zhong,Ru Ji,Ming Zhang,Houcheng You,Kefeng Dou,Kaishan Tao.Erratum: Tg737 inhibition results in malignant transformation in fetal liver stem/progenitor cells by promoting cell‐cycle progression and differentiation arrest[J]. Mol. Carcinog. . 2011 (10) 被引量:1
  • 5Yali Jia,Hailei Yao,Junnian Zhou,Lin Chen,Quan Zeng,Hongfeng Yuan,Lei Shi,Xue Nan,Yunfang Wang,Wen Yue,Xuetao Pei.Role of epimorphin in bile duct formation of rat liver epithelial stem‐like cells: Involvement of small G protein RhoA and C/EBPβ[J]. J. Cell. Physiol. . 2011 (11) 被引量:1
  • 6Francesco Paolo Russo,Maurizio Parola.Stem and progenitor cells in liver regeneration and repair[J]. Cytotherapy . 2011 (2) 被引量:1
  • 7Pau Sancho-Bru.Posibilidades terapéuticas de las células madre en el tratamiento de las enfermedades hepáticas[J]. Gastroenterologia y Hepatologia . 2011 (10) 被引量:1
  • 8Russell N. Wesson,Andrew M. Cameron.Stem Cells in Acute Liver Failure[J]. Advances in Surgery . 2011 (1) 被引量:1
  • 9Ningfu Peng,Lequn Li,Xiang Cai,Shaozao Tan,Ting Wu.Liver Stem/Progenitor Cells in the Canals of Hering: Cellular Origin of Hepatocellular Carcinoma with Bile Duct Tumor Thrombi?[J]. Stem Cell Reviews and Reports . 2010 (4) 被引量:1
  • 10Jennifer M. Williams,Seh-Hoon Oh,Marda Jorgensen,Nicole Steiger,Houda Darwiche,Thomas Shupe,Bryon E. Petersen.The Role of the Wnt Family of Secreted Proteins in Rat Oval “Stem” Cell-Based Liver Regeneration[J]. The American Journal of Pathology . 2010 (6) 被引量:1

二级参考文献14

  • 1Mathis DL, Vence L, Benoist C. beta-Cell death during progression to diabetes. Nature 2001,414:792-8. 被引量:1
  • 2Bonner-Weir S, Sharma A. Pancreatic stem cells. J Pathol 2002,197:519-26. 被引量:1
  • 3Oberholzer J, Triponez F, Mage R, et al. Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantations. Transplantation 2000, 69:1115-23. 被引量:1
  • 4Grompe M. Pancreatic-hepatic switches in vivo. Mech Dev 2003,120:99-106. 被引量:1
  • 5McLin VA, Zorn AM. Organogenesis: making pancreas from liver. Curt Biol 2003,13:R96-8. 被引量:1
  • 6Suzuki A, Zheng YW, Kaneko S, et al. Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver. J Cell Biol 2002, 156:173-84. 被引量:1
  • 7Horb ME, Shen CN, Tosh D, Slack JM. Experimental conversion of liver to pancreas. Curt Biol 2003,13:105-15. 被引量:1
  • 8Kojima H, Nakamura T, Fujita Y, et al. Combined expression of pancreatic duodenal homeobox 1 and islet factor 1 induces immature enterocytes to produce insulin. Diabetes 2002,51:1398-408. 被引量:1
  • 9Suzuki A, Nakauchi H, Taniguchi H. Glucagon-like peptide 1(1-37) converts intestinal epithelial cells into insulin-producing cells.Proc Natl Acad Sci U S A 2003,100:5034-9. 被引量:1
  • 10Yang L, Li S, Hatch H, et al. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci U S A 2002,99:8078-83. 被引量:1

共引文献8

同被引文献15

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部